HLA-G genotype and HLA-G expression in systemic lupus erythematosus: HLA-G as a putative susceptibility gene in systemic lupus erythematosus

Tissue Antigens

Volumn 71, Issue 6, 2008, Pages 520-529

  Rizzo, R ^a   Hviid, T V F ^b,c   Govoni, M ^d   Padovan, M ^d   Rubini, M ^a   Melchiorri, L ^a   Stignani, M ^a   Carturan, S ^a   Grappa, M T ^a   Fotinidi, M ^d   Ferretti, S ^a   Voss, A ^e   Laustrup, H ^e   Junker, P ^e   Trotta, F ^d   Baricordi, O R ^a  

^a UNIVERSITY OF FERRARA   (Italy)

^b ROSKILDE HOSPITAL   (Denmark)

^c HILLERØD HOSPITAL   (Denmark)

^d S ANNA HOSPITAL   (Italy)

^e ODENSE UNIVERSITY HOSPITAL   (Denmark)

Author keywords

Autoimmune disease; Human leukocyte antigen G; Interleukin 10; Systemic lupus erythematosus

Indexed keywords

HLA G ANTIGEN; INTERLEUKIN 10; MESSENGER RNA;

ADULT; ANTIGEN EXPRESSION; ARTICLE; AUTOIMMUNE DISEASE; CELLULAR IMMUNITY; CONTROLLED STUDY; DENMARK; FEMALE; GENE INSERTION; GENETIC POLYMORPHISM; GENETIC SUSCEPTIBILITY; GENOTYPE; HUMAN; IMMUNOPATHOGENESIS; INNATE IMMUNITY; ITALY; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; SYSTEMIC LUPUS ERYTHEMATOSUS;

ADULT; ANTIGEN-ANTIBODY COMPLEX; ANTIGEN-PRESENTING CELLS; DENMARK; FEMALE; GENE EXPRESSION REGULATION; GENETIC PREDISPOSITION TO DISEASE; HISTOCOMPATIBILITY ANTIGENS CLASS I; HLA ANTIGENS; HUMANS; IMMUNITY, CELLULAR; IMMUNITY, NATURAL; INTERLEUKIN-10; ITALY; LUPUS ERYTHEMATOSUS, SYSTEMIC; MALE; MIDDLE AGED; POLYMORPHISM, GENETIC; RNA STABILITY; RNA, MESSENGER; TH2 CELLS;

EID: 43849108272     PISSN: 00012815     EISSN: 13990039     Source Type: Journal    
DOI: 10.1111/j.1399-0039.2008.01037.x     Document Type: Article

References (60)

1. Gottlieb AB, Lahita RG, Chiorazzi N, Kunkel HG. Immune function in systemic lupus erythematosus. Impairment of in vitro T cell proliferation and in vivo antibody response to exogenous antigen. J Clin Invest 1979 : 63 : 885 92.
2. O'Shea JJ, Ma A, Lipsky P. Cytokines and autoimmunity. Nat Rev Immunol 2002 : 2 : 37 45.
3. Schur PH. Genetics of systemic lupus erythematosus lupus. 1995 : 4 : 425 37.
4. Ibnou-Zekri N, Vyse TJ, Rozzo SJ et al. MHC linked control of murine SLE. Curr Top Microbiol Immunol 1999 : 246 : 275 80.
5. Forabaso P, Gormon JD, Cleveland C et al. Meta-analysis of genome-wide linkage studies of systemic lupus erythematosus. Genes Immun 2006 : 7 : 609 14.
6. Carosella ED, Moreau P, Aractingi S, Rouas-Freiss N. HLA-G: a shield against inflammatory aggression. Trends Immunol 2001 : 10 : 553 5.
7. Fujii T, Ishitani A, Geraghty DE. A soluble form of the HLA-G antigen is encoded by a messenger ribonucleic acid containing intron 4. J Immunol 1994 : 153 : 5516 24.
8. Rouas-Freiss N, Marchal RE, Kirszenbaum M, Dausset J, Carosella ED. The alpha1 domain of HLA-G1 and HLA-G2 inhibits cytotoxicity induced by natural killer cells: is HLA-G the public ligand for natural killer cell inhibitory receptors? Proc Natl Acad Sci U S A 1997 : 94 : 5249 54.
9. Fournel S, Aguerre-Girr M, Huc X et al. Cutting edge: soluble HLA-G1 triggers CD95/CD95 ligand-mediated apoptosis in activated CD8+ cells by interacting with CD8. J Immunol 2000 : 164 : 6100 4.
10. Bainbridge DR, Ellis SA, Sargent IL. HLA-G suppresses proliferation of CD4(+) T-lymphocytes. J Reprod Immunol 2000 : 48 : 17 26.
11. Crisa L, McMaster MT, Ishii JK, Fisher SJ, Salomon DR. Identification of a thymic epithelial cell subset sharing expression of the class Ib HLA-G molecule with fetal trophoblasts. J Exp Med 1997 : 186 : 289 98.
12. Moreau P, Adrian-Cabestre F, Menier C et al. IL-10 selectively induces HLA-G in human trophoblast and monocytes. Int Immunol 1999 : 5 : 803 11.
13. Seliger B, Abken H, Ferrone S. HLA-G and MIC expression in tumors and their role in anti-tumor immunity. Trends Immunol 2003 : 24 : 82 7.
14. Rebmann V, Regel J, Stolke D, Grosse-Wilde H. Secretion of sHLA-G molecules in malignancies. Semin Cancer Biol 2003 : 13 : 371 7.
15. Onno M, Pangault C, Le Friec G, Guilloux V, Andre P, Fauchet R. Modulation of HLA-G antigen expression by human cytomegalovirus: specific induction in activated macrophages harboring human cytomegalovirus infection. J Immunol 2000 : 164 : 6426 34.
16. Lozano JM, Gonzales R, Kindelan JM et al. Monocytes and T lymphocytes in HIV-1 positive patients express HLA-G molecules. AIDS 2002 : 16 : 347 51.
17. Lila N, Amrein C, Guillemain R et al. Human leukocyte antigen -G expression after heart transplantation is associated with a reduced incidence of rejection. Circulation 2002 : 105 : 1949 54.
18. Creput C, Le Friec G, Bahri R et al. Detection of HLA-G in serum and graft biopsy associated with fewer acute rejections following combined liver-kidney transplantation: possible implications for monitoring patients. Hum Immunol 2003 : 11 : 1033 8.
19. Rizzo R, Mapp CE, Melchiorri L et al. Defective production of soluble HLA-G molecules by peripheral blood monocytes in patients with asthma. J Allergy Clin Immunol 2005 : 115 : 508 13.
20. Fainardi E, Rizzo R, Melchiorri L et al. Presence of detectable levels of soluble HLA-G molecules in CSF of relapsing-remitting multiple sclerosis: relationship with CSF soluble HLA-I and IL-10 concentrations and MRI findings. J Neuroimmunol 2003 : 142 : 149 58.
21. Ober C, Rosinsky B, Grimsley C, van der Ven K, Robertson A, Runge A. Population genetic studies of HLA-G: allele frequencies and linkage disequilibrium with HLA-A1. J Reprod Immunol 1996 : 32 : 111 23.
22. Yamashita T, Fujii T, Watanabe Y et al. HLA-G gene polymorphism in a Japanese population. Immunogenetics 1996 : 44 : 186 91.
23. Hviid TV, Meldgaard M, Sorensen S, Morling N. Polymorphism of exon 3 of the HLA-G gene. J Reprod Immunol 1997 : 35 : 31 42.
24. Ishitani A, Kishida M, Sageshima N et al. Re-examination of HLA-G polymorphism in African Americans. Immunogenetics 1999 : 49 : 808 11.
25. Harrison GA, Humphrey KE, Jacobsen IB, Cooper DW. A 14 bp deletion polymorphism in the HLA-G gene. Hum Mol Genet 1993 : 2 : 2200.
26. Hviid TV, Rizzo R, Christiansen OB, Melchiorri L, Lindhard A, Baricordi OR. HLA-G and IL-10 in serum in relation to HLA-G genotype and polymorphisms. Immunogenetics 2004 : 56 : 135 41.
27. Hagiwara E, Gourley MF, Lee S, Klinman DK. Disease severity in patients with lupus erythematosus correlates with an increased ratio of interleukin-10/interferon - gamma-secreting cells in the peripheral blood. Arthritis Rheum 1996 : 39 : 379 85.
28. Hochberg MC. Updating the American College of Rheumatology revised criteria for the classification of systemic lupus erythematosus. Arthritis Rheum 1997 : 40 : 1725.
29. Vitali C, Bencivelli W, Isenberg DA et al. Disease activity in systemic lupus erythematosus: report of the Consensus Study Group of the European Workshop for Rheumatology Research. I. A descriptive analysis of 704 European lupus patients. European Consensus Study Group for Disease Activity in SLE. Clin Exp Rheumatol 1992 : 10 : 527 39.
30. Tan EM, Feltkamp TE, Smolen JS et al. Range of antinuclear antibodies in "healthy" individuals. Arthritis Rheum 1997 : 40 : 1601 11.
31. Hviid TV, Hylenius S, Hoegh AM, Kruse C, Christiansen OB. HLA-G polymorphisms in couples with recurrent spontaneous abortions. Tissue Antigens 2002 : 60 : 122 32.
32. Rebmann V, Lemaoult J, Rouas-Freiss N, Carosella ED, Grosse-Wilde H. Report of the Wet Workshop for Quantification of Soluble HLA-G in Essen. Hum Immunol 2004 : 66 : 853 63.
33. Le Friec G, Laupeze B, Fardel O et al. Soluble HLA-G inhibits human dendritic cell-triggered allogeneic T-cell proliferation without altering dendritic differentiation and maturation processes. Hum Immunol 2003 : 64 : 752 61.
34. Stephens M, Smith NJ, Donnelly P. A new statistical method for haplotype reconstruction from population data. Am J Hum Genet 2001 : 68 : 978 89.
35. Stephens M, Donnelly P. Inference in molecular population genetics. Journal of The Royal Statistical Society Series B 2000 : 62 : 605 55.
36. Ober C, Aldrich CL, Chervoneva I et al. Variation in the HLA-G promoter region influences miscarriage rates. Am J Hum Genet 2003 : 72 : 14225 35.
37. Hviid TV, Hylenius S, Rorbye C, Nielsen LG. HLA-G allelic variants are associated with differences in the HLA-G mRNA isoform profile and HLA-G mRNA levels. Immunogenetics 2003 : 55 : 63 79.
38. Rousseau P, Le Discorde M, Mouillot G, Marcou C, Carosella ED, Moreau P. The 14 bp deletion-insertion polymorphism in the 3' UT region of the HLA-G gene influences HLA-G mRNA stability. Hum Immunol 2003 : 64 : 1005 10.
39. Rizzo R, Hviid TV, Stignani M et al. HLA-G genotype is associated with IL-10 levels in activated PBMC. Immunogenetics 2005 : 57 : 172 81.
40. Gladman DD, Urowitz MB, Darlington GA. Disease expression and class II HLA antigens in systemic lupus erythematosus. Lupus 1999 : 8 : 466 70.
41. Rood MJ, van Krugten MV, Zanelli E et al. TNF-308A and HLA-DR3 alleles contribute independently to susceptibility to systemic lupus erythematosus. Arthritis Rheum 2000 : 43 : 129 34.
42. Hviid TV, Christiansen OB. Linkage disequilibrium between human leukocyte antigen (HLA) class II and HLA-G-possible implications for human reproduction and autoimmune disease. Hum Immunol 2005 : 66 : 688 99.
43. Hunt JS, Petroff MG, McIntire RH, Ober C. HLA-G and immune tolerance in pregnancy. FASEB J 2005 : 19 : 681 93.
44. Kanai T, Fujii T, Unno N et al. Human leukocyte antigen-G expressing cells differently modulate the release of cytokines from mononuclear cells present in the deciduas versus peripheral blood. Am J Reprod Immunol 2001 : 45 : 94 9.
45. Hara N, Fujii T, Yamashita T, Kozuma S, Okai T, Taketani Y. Altered expression of human leukocyte antigen G (HLA-G) on extravillous trophoblasts in preeclampsia: immunohistological demonstration with anti-HLA-G specific antibody "87G" and anti-cytokeratin antibody "CAM5.2". Am J Reprod Immunol 1996 : 36 : 349 58.
46. Yie SM, Taylor RN, Librach C. Low plasma HLA-G protein concentrations in early gestation indicate the development of preeclampsia later in pregnancy. Am J Obstet Gynecol 2005 : 193 : 204 8.
47. O'Brien M, McCarthy T, Jenkins D et al. Altered HLA-G transcription in pre-eclampsia is associated with allele specific inheritance: possible role of the HLA-G gene in susceptibility to the disease. Cell Mol Life Sci 2001 : 58 : 1943 9.
48. Hylenius S, Andersen AM, Melbye M, Hviid TV. Association between HLA-G genotype and risk of pre-eclampsia: a case-control study using family triads. Mol Hum Reprod 2004 : 10 : 237 46.
49. Hviid TV, Hylenius S, Lindhard A, Christiansen OB. Association between human leukocyte antigen-G genotype and success of in vitro fertilization and pregnancy outcome. Tissue Antigens 2004 : 64 : 66 9.
50. Lockshin MD, Sammaritano LR. Lupus pregnancy. Autoimmunity 2003 : 36 : 33 40.
51. Faussett MB, Branch DW. Autoimmunity and pregnancy loss. Semin Reprod Med 2000 : 18 : 379 92.
52. Burfoot RK, Jensen CJ, Field J et al. SNP mapping and candidate gene sequencing in the class I region of the HLA complex: searching for multiple sclerosis susceptibility genes in Tasmanians. Tissue Antigens 2007 : 71 : 42 50.
53. Glas J, Török HP, Tonenchi L et al. The 14-bp deletion polymorphism in the HLA-G gene displays significant differences between ulcerative colitis and Crohn's disease and is associated with ileocecal resection in Crohn's disease. Int Immunol 2007 : 19 : 621 6.
54. Nicolae D, Cox NJ, Lester LA et al. Fine mapping and positional candidate studies identify HLA-G as an asthma susceptibility gene on chromosome 6p21. Am J Hum Genet 2005 : 76 : 349 57.
55. Grondal G, Traustadottir KH, Kristjansdottir H et al. Increased T-lymphocyte apoptosis/necrosis and IL-10 producing cells in patients and their spouses in Icelandic systemic lupus erythematosus multicase families. Lupus 2002 : 11 : 435 42.
56. Enghard P, Langnickel D, Riemekasten G. T cell cytokine imbalance towards production of IFN-gamma and IL-10 in NZB/W F1 lupus-prone mice is associated with autoantibody levels and nephritis. Scand J Rheumatol 2006 : 35 : 209 16.
57. Chen CJ, Lin KH, Lin SC et al. High prevalence of immunoglobulin A antibody against Epstein-Barr virus capsid antigen in adult patients with lupus with disease flare: case control studies. J Rheumatol 2005 : 32 : 44 7.
58. Parks CG, Cooper GS, Hudson LL et al. Association of Epstein-Barr virus with systemic lupus erythematosus: effect modification by race, age, and cytotoxic T lymphocyte-associated antigen 4 genotype. Arthritis Rheum 2005 : 52 : 1148 59.
59. Vieira P, de Waal-Malefyt R, Dang MN et al. Isolation and expression of human cytokine synthesis inhibitory factor cDNA clones: homology to Epstein-Barr virus open reading frame BCRFI. Proc Natl Acad Sci U S A 1991 : 88 : 1172 6.
60. Salek-Ardakani S, Arrand JR, Mackett M. Epstein-Barr virus encoded interleukin-10 inhibits HLA-class I, ICAM-1, and B7 expression on human monocytes: implications for immune evasion by EBV. Virology 2002 : 304 : 342 51.